Cargando…
Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia
Ischemia occurs when blood flow is reduced or restricted, leading to a lack of oxygen and nutrient supply and removal of metabolites in a body part. Critical limb ischemia (CLI) is a severe clinical manifestation of peripheral arterial disease. Atherosclerosis serves as the main cause of CLI, which...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866736/ https://www.ncbi.nlm.nih.gov/pubmed/35243296 http://dx.doi.org/10.1016/j.mtbio.2022.100221 |
_version_ | 1784655897357713408 |
---|---|
author | Costa, Ana Letícia Rodrigues Willerth, Stephanie M. de la Torre, Lucimara Gaziola Han, Sang Won |
author_facet | Costa, Ana Letícia Rodrigues Willerth, Stephanie M. de la Torre, Lucimara Gaziola Han, Sang Won |
author_sort | Costa, Ana Letícia Rodrigues |
collection | PubMed |
description | Ischemia occurs when blood flow is reduced or restricted, leading to a lack of oxygen and nutrient supply and removal of metabolites in a body part. Critical limb ischemia (CLI) is a severe clinical manifestation of peripheral arterial disease. Atherosclerosis serves as the main cause of CLI, which arises from the deposition of lipids in the artery wall, forming atheroma and causing inflammation. Although several therapies exist for the treatment of CLI, pharmacotherapy still has low efficacy, and vascular surgery often cannot be performed due to the pathophysiological heterogeneity of each patient. Gene and cell therapies have emerged as alternative treatments for the treatment of CLI by promoting angiogenesis. However, the delivery of autologous, heterologous or genetically modified cells into the ischemic tissue remains challenging, as these cells can die at the injection site and/or leak into other tissues. The encapsulation of these cells within hydrogels for local delivery is probably one of the promising options today. Hydrogels, three-dimensional (3D) cross-linked polymer networks, enable manipulation of physical and chemical properties to mimic the extracellular matrix. Thus, specific biostructures can be developed by adjusting prepolymer properties and encapsulation process variables, such as viscosity and flow rate of fluids, depending on the final biomedical application. Electrostatic droplet extrusion, micromolding, microfluidics, and 3D printing have been the most commonly used technologies for cell encapsulation due to their versatility in producing different hydrogel-based systems (e.g., microgels, fibers, vascularized architectures and perfusable single vessels) with great potential to treat ischemic diseases. This review discusses the cell encapsulation technologies associated with hydrogels which are currently used for advanced therapies applied to limb ischemia, describing their principles, advantages, disadvantages, potentials, and innovative therapeutic ideas. |
format | Online Article Text |
id | pubmed-8866736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-88667362022-03-02 Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia Costa, Ana Letícia Rodrigues Willerth, Stephanie M. de la Torre, Lucimara Gaziola Han, Sang Won Mater Today Bio Review Article Ischemia occurs when blood flow is reduced or restricted, leading to a lack of oxygen and nutrient supply and removal of metabolites in a body part. Critical limb ischemia (CLI) is a severe clinical manifestation of peripheral arterial disease. Atherosclerosis serves as the main cause of CLI, which arises from the deposition of lipids in the artery wall, forming atheroma and causing inflammation. Although several therapies exist for the treatment of CLI, pharmacotherapy still has low efficacy, and vascular surgery often cannot be performed due to the pathophysiological heterogeneity of each patient. Gene and cell therapies have emerged as alternative treatments for the treatment of CLI by promoting angiogenesis. However, the delivery of autologous, heterologous or genetically modified cells into the ischemic tissue remains challenging, as these cells can die at the injection site and/or leak into other tissues. The encapsulation of these cells within hydrogels for local delivery is probably one of the promising options today. Hydrogels, three-dimensional (3D) cross-linked polymer networks, enable manipulation of physical and chemical properties to mimic the extracellular matrix. Thus, specific biostructures can be developed by adjusting prepolymer properties and encapsulation process variables, such as viscosity and flow rate of fluids, depending on the final biomedical application. Electrostatic droplet extrusion, micromolding, microfluidics, and 3D printing have been the most commonly used technologies for cell encapsulation due to their versatility in producing different hydrogel-based systems (e.g., microgels, fibers, vascularized architectures and perfusable single vessels) with great potential to treat ischemic diseases. This review discusses the cell encapsulation technologies associated with hydrogels which are currently used for advanced therapies applied to limb ischemia, describing their principles, advantages, disadvantages, potentials, and innovative therapeutic ideas. Elsevier 2022-02-16 /pmc/articles/PMC8866736/ /pubmed/35243296 http://dx.doi.org/10.1016/j.mtbio.2022.100221 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Costa, Ana Letícia Rodrigues Willerth, Stephanie M. de la Torre, Lucimara Gaziola Han, Sang Won Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia |
title | Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia |
title_full | Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia |
title_fullStr | Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia |
title_full_unstemmed | Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia |
title_short | Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia |
title_sort | trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866736/ https://www.ncbi.nlm.nih.gov/pubmed/35243296 http://dx.doi.org/10.1016/j.mtbio.2022.100221 |
work_keys_str_mv | AT costaanaleticiarodrigues trendsinhydrogelbasedencapsulationtechnologiesforadvancedcelltherapiesappliedtolimbischemia AT willerthstephaniem trendsinhydrogelbasedencapsulationtechnologiesforadvancedcelltherapiesappliedtolimbischemia AT delatorrelucimaragaziola trendsinhydrogelbasedencapsulationtechnologiesforadvancedcelltherapiesappliedtolimbischemia AT hansangwon trendsinhydrogelbasedencapsulationtechnologiesforadvancedcelltherapiesappliedtolimbischemia |